415 related articles for article (PubMed ID: 17632186)
1. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
Gilling KE; Jatzke C; Parsons CG
Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
[TBL] [Abstract][Full Text] [Related]
2. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
3. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
4. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies.
Liu YW; Luo JL; Ren H; Peoples RW; Ai YX; Liu LJ; Pang YP; Li ZW; Han YF; Li CY
Neuropharmacology; 2008 Jun; 54(7):1086-94. PubMed ID: 18407299
[TBL] [Abstract][Full Text] [Related]
6. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker.
Parsons CG; Gilling K
Methods Mol Biol; 2007; 403():15-36. PubMed ID: 18827985
[TBL] [Abstract][Full Text] [Related]
7. Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block.
Mealing GA; Lanthorn TH; Murray CL; Small DL; Morley P
J Pharmacol Exp Ther; 1999 Jan; 288(1):204-10. PubMed ID: 9862772
[TBL] [Abstract][Full Text] [Related]
8. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
9. Differential responses to NMDA receptor activation in rat hippocampal interneurons and pyramidal cells may underlie enhanced pyramidal cell vulnerability.
Avignone E; Frenguelli BG; Irving AJ
Eur J Neurosci; 2005 Dec; 22(12):3077-90. PubMed ID: 16367774
[TBL] [Abstract][Full Text] [Related]
10. The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons.
Noh J; Lee ES; Chung JM
J Neurochem; 2009 Jun; 109(5):1261-71. PubMed ID: 19302475
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
Hershkowitz N; Rogawski MA
Mol Pharmacol; 1991 May; 39(5):592-8. PubMed ID: 1709720
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism.
Chen HS; Lipton SA
J Physiol; 1997 Feb; 499 ( Pt 1)(Pt 1):27-46. PubMed ID: 9061638
[TBL] [Abstract][Full Text] [Related]
13. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
Subramaniam S; Donevan SD; Rogawski MA
J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
[TBL] [Abstract][Full Text] [Related]
14. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N
J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
16. Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons.
Maler JM; Esselmann H; Wiltfang J; Kunz N; Lewczuk P; Reulbach U; Bleich S; Rüther E; Kornhuber J
Brain Res; 2005 Aug; 1052(2):156-62. PubMed ID: 16009352
[TBL] [Abstract][Full Text] [Related]
17. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.
Parsons CG; Panchenko VA; Pinchenko VO; Tsyndrenko AY; Krishtal OA
Eur J Neurosci; 1996 Mar; 8(3):446-54. PubMed ID: 8963435
[TBL] [Abstract][Full Text] [Related]
18. Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons.
Baptista V; Varanda WA
J Neurophysiol; 2005 Jul; 94(1):147-52. PubMed ID: 15744010
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL 15896AR.
Mealing GA; Lanthorn TH; Small DL; Black MA; Laferriere NB; Morley P
J Pharmacol Exp Ther; 1997 Apr; 281(1):376-83. PubMed ID: 9103520
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
Grauert M; Rho JM; Subramaniam S; Rogawski MA
J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
